Atomically detailed, physics-based MD simulation methods are demonstrating growing impact in areas as diverse as biocatalysis, biomaterials, biotechnology, and drug design. Such simulations offer uniquely detailed insights at high time-and space-resolution into mechanisms, dynamics, and processes. Particularly important for the (re)design of enzymes as biocatalysts is assessment of the effect of mutations, for which static structural modelling alone is of limited use.